Aprecia Pharmaceuticals – Corporate HQ
7200 Industrial Row Drive
Suite 200
Mason, OH 45040
(513) 984-5000
contact@aprecia.com
LinkedIn | YouTube
Aprecia is a specialty CDMO offering commercial-scale production systems designed to accelerate clinical development and optimize commercial success. Our industry-leading 3DP formulation and manufacturing platforms transform drug development and delivery, meeting the unprecedented demand for complex and patient-friendly dosage forms.
- SPEED – Aprecia’s 3DP platform reduces timelines and cost in oral solid dosage development by enabling a single formulation, single process, and single manufacturing platform from pre-formulation through commercial launch.
- FLEXIBILITY – Aprecia uniquely provides dose flexibility, rapid clinical supply, and manufacturability beyond what traditional tablets or capsules can support.
- PRECISION – Minimize CMC and investment risk by integrating formulation, process and equipment from pre-formulation through commercial manufacturing and primary packaging – reducing the need for bridging studies, comparability risk and revalidation. Quality is strengthened through real-time quality verification using on-machine process analytical technologies.
Our Services
Aprecia’s application of advanced technologies in precision formulation, oral drug delivery, and binder jet 3DP production gives you the flexibility you need to streamline development and accelerate speed to market.
- Contract Development and Manufacturing Organization (CDMO)
- Clinical Trials (Phase I – III)
- Drug Delivery
- Solutions to overcome formulation challenges
- Taste masking
- Customized drug release
- Solubility enhancement
- ODTs, OSD & novel dosage forms
- Easily swallowed dosage forms for patients with difficulty swallowing
- Optimize efficacy, safety, & dosing frequency
- Increase therapeutic performance & patient acceptability
- Maximize dosing accuracy, flexibility, convenience
- Development
- Formulation Development
- Dosage Form Development
- Analytical method development & validation
- Prototype development
- Small-scale non-GMP & GMP development capabilities
- Manufacturing
- Seamless scale-up & tech transfer
- Clinical & Commercial Scale Manufacturing
- Process Analytical technology (PAT)
Resource Center
Posted Date: 7/7/2026
This record has been viewed 126 times.
